James D. Marks
- Radiology, Nuclear Medicine and Imaging top 0.05%
- Monoclonal and Polyclonal Antibodies Research 112
- Biomaterials top 0.5%
- Neurology top 0.5%
- Botulinum Toxin and Related Neurological Disorders 56
- Neurological disorders and treatments 41
- Molecular Biology top 0.5%
- Glycosylation and Glycoproteins Research 61
- Protein purification and stability 22
- Advanced Biosensing Techniques and Applications 18
- Immunology top 1%
-
- Hereditary Neurological Disorders 30
-
- HER2/EGFR in Cancer Research 22
- Co-authors
- Greg WinterDmitri B. KirpotinGregory P. AdamsUlrik B. NielsenJianlong LouKeelung HongChristopher C. BenzDaryl C. Drummond
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
James D. Marks
209 papers receiving 14.5k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Radiology, Nuclear Medicine and Imaging 7.5k
- Biomaterials 1.8k
- Neurology 2.1k
- Molecular Biology 8.0k
- Immunology 2.4k
Countries citing papers authored by James D. Marks
This map shows the geographic impact of James D. Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James D. Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James D. Marks more than expected).
Fields of papers citing papers by James D. Marks
This network shows the impact of papers produced by James D. Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James D. Marks. The network helps show where James D. Marks may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James D. Marks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 3 | |
| 2 | 2021 | 22 | |
| 3 | 2014 | 24 | |
| 4 | 2012 | 54 | |
| 5 | 2011 | 270 | |
| 6 | 2011 | 54 | |
| 7 | 2010 | 40 | |
| 8 | 2009 | 43 | |
| 9 | 2007 | 103 | |
| 10 | 2006 | 78 | |
| 11 | Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal Modelsbreakdown → | 2006 | 863 |
| 12 | Anti-HER2 Immunoliposomes | 2002 | 10 |
| 13 | Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.breakdown → | 2002 | 518 |
| 14 | 2001 | 246 | |
| 15 | Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity. | 2000 | 97 |
| 16 | 2000 | 72 | |
| 17 | 1999 | 114 | |
| 18 | Increased affinity leads to improved selective tumor delivery of single-chain Fv antibodies. | 1998 | 182 |
| 19 | 1996 | 58 | |
| 20 | 1993 | 5 |
About James D. Marks
James D. Marks is a scholar working on Radiology, Nuclear Medicine and Imaging, Neurology and Cellular and Molecular Neuroscience, having authored 211 papers that have together received 15.1k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (112 papers), Glycosylation and Glycoproteins Research (61 papers), Botulinum Toxin and Related Neurological Disorders (56 papers), Neurological disorders and treatments (41 papers), Hereditary Neurological Disorders (30 papers), Protein purification and stability (22 papers), HER2/EGFR in Cancer Research (22 papers) and Advanced Biosensing Techniques and Applications (18 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (7.5k citations), Biomaterials (1.8k citations) and Neurology (2.1k citations). James D. Marks has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Greg Winter, Dmitri B. Kirpotin, Gregory P. Adams, Ulrik B. Nielsen, Jianlong Lou, Keelung Hong, Christopher C. Benz, Daryl C. Drummond, John W. Park and Robert Schier. Their work appears in journals such as Journal of Molecular Biology, Cancer Research, Toxins, PLoS ONE and Protein Engineering Design and Selection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.